Condition
Elbow Epicondylitis: Options and What the Evidence Actually Shows
Tennis and golfer's elbow are tendinopathies. Load management comes first.
Anatomy and clinical context
Lateral and medial epicondylalgia are overload injuries of the common extensor or flexor origins.
Most resolve with time and eccentric loading; injections are for refractory cases.
Illustration of the elbow joint
The standard-of-care ladder
Conservative care first, then injections, then surgery when indicated. Cell therapy belongs in that conversation — not above it.
- Step 1
Conservative care
Load management, eccentric exercise, bracing.
- Step 2
Injections
PRP or corticosteroid in refractory cases — know the tradeoffs.
- Step 3
Surgery
Surgical debridement when nonoperative care fails.
Where cell therapy fits
PRP evidence is mixed; MSC same-day products are not the center of this story.
- Expect months of rehab, not overnight fixes.
- PRP protocols differ — ask for details.
- Banking is optional context for broader plans.
Selected citations
Shapiro 2017
Shapiro et al. · AJSM (2017)
BMAC vs saline in the same patient's other knee — no difference on primary outcomes.
Why dose and donor age change the picture
The trials that disappoint used unexpanded cells from older donors.
The ones that work used expanded cells at therapeutic dose. Dose is the variable — and dose is what expansion buys you. Potency is what your age buys you.
- 1
Cells work at dose.
A same-day draw yields a small, uncounted, unexpanded fraction. Expansion turns one draw into many doses.
- 2
Potency is age-dependent, and it is a one-way door.
Your MSCs at 35 are not your MSCs at 55. Banking is the only mechanism that makes 35-year-old cells available to a 55-year-old.
- 3
Expansion is what makes the bank a supply, not a souvenir.
Bank once, expand repeatedly, across a treatment course rather than a single shot. Culture expansion for Forever Labs members is rolling out — starting with selected states as our Florida cGMP lab comes online.
- 4
The provider decides what happens next.
We supply cells; they practice medicine. Forever Labs does not treat conditions — your physician owns the clinical relationship.
Two next steps — equal weight
Forever Labs does not treat conditions. Your physician owns the clinical relationship. We bank cells and, as expansion rolls out, help make dose possible.